Legal & General Group
NMRD

Legal & General Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Legal & General Group’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,106
Closed -$9K – 3690
2021
Q1 		$9K Hold
1,106
– – ﹤0.01% 3414
2020
Q4 		$4K Hold
1,106
– – ﹤0.01% 3452
2020
Q3 		$4K Hold
1,106
– – ﹤0.01% 3404
2020
Q2 		$10K Buy
+1,106
New +$7.89K ﹤0.01% 3318

Other funds holding NMRD

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Legal & General Group's NMRD Position: Q2 2021 in Review

Legal & General Group sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q2 2021, closing a stake of 1,106 shares — an estimated $9K sold.

Legal & General Group first reported a position in NMRD in Q2 2020 and held it in 4 quarters. The position peaked at $10K in Q2 2020. 29 funds tracked by Wall St. Rank hold NMRD as of Q2 2021.

  • Legal & General Group reported no remaining Nemaura Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 1,106 Nemaura Medical, Inc. Common Stock shares in Q2 2021, an estimated $9K.
  • Legal & General Group first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Legal & General Group's Nemaura Medical, Inc. Common Stock position peaked at $10K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.